Liu J, Liu Y, Xu W, Zhang M, et al. Evaluation of efficacy of iGlarLixi versus IDegAsp using derived time-in-ranges in Chinese adults with Type 2 diabetes: A post hoc analysis of the Soli-D study. Diabetes Obes Metab 2025 Jul 25. doi: 10.1111/dom.16646.
PMID: 40709642